Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins
- PMID: 21384047
- PMCID: PMC3652547
- DOI: 10.1039/c0dt01321h
Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins
Abstract
Cationic Mn(III) N-alkylpyridylporphyrins (MnPs) are potent SOD mimics and peroxynitrite scavengers and diminish oxidative stress in a variety of animal models of central nervous system (CNS) injuries, cancer, radiation, diabetes, etc. Recently, properties other than antioxidant potency, such as lipophilicity, size, shape, and bulkiness, which influence the bioavailability and the toxicity of MnPs, have been addressed as they affect their in vivo efficacy and therapeutic utility. Porphyrin bearing longer alkyl substituents at pyridyl ring, MnTnHex-2-PyP(5+), is more lipophilic, thus more efficacious in vivo, particularly in CNS injuries, than the shorter alkyl-chained analog, MnTE-2-PyP(5+). Its enhanced lipophilicity allows it to accumulate in mitochondria (relative to cytosol) and to cross the blood-brain barrier to a much higher extent than MnTE-2-PyP(5+). Mn(III) N-alkylpyridylporphyrins of longer alkyl chains, however, bear micellar character, and when used at higher levels, become toxic. Recently we showed that meta isomers are ∼10-fold more lipophilic than ortho species, which enhances their cellular accumulation, and thus reportedly compensates for their somewhat inferior SOD-like activity. Herein, we modified the alkyl chains of the lipophilic meta compound, MnTnHex-3-PyP(5+) via introduction of a methoxy group, to diminish its toxicity (and/or enhance its efficacy), while maintaining high SOD-like activity and lipophilicity. We compared the lipophilic Mn(III) meso-tetrakis(N-(6'-methoxyhexyl)pyridinium-3-yl)porphyrin, MnTMOHex-3-PyP(5+), to a hydrophilic Mn(III) meso-tetrakis(N-(2'-methoxyethyl)pyridinium-3-yl)porphyrin, MnTMOE-3-PyP(5+). The compounds were characterized by uv-vis spectroscopy, mass spectrometry, elemental analysis, electrochemistry, and ability to dismute O(2)˙(-). Also, the lipophilicity was characterized by thin-layer chromatographic retention factor, R(f). The SOD-like activities and metal-centered reduction potentials for the Mn(III)P/Mn(II)P redox couple were similar-to-identical to those of N-alkylpyridyl analogs: log k(cat) = 6.78, and E(1/2) = +68 mV vs. NHE (MnTMOHex-3-PyP(5+)), and log k(cat) = 6.72, and E(1/2) = +64 mV vs. NHE (MnTMOE-3-PyP(5+)). The compounds were tested in a superoxide-specific in vivo model: aerobic growth of SOD-deficient E. coli, JI132. Both MnTMOHex-3-PyP(5+) and MnTMOE-3-PyP(5+) were more efficacious than their alkyl analogs. MnTMOE-3-PyP(5+) is further significantly more efficacious than the most explored compound in vivo, MnTE-2-PyP(5+). Such a beneficial effect of MnTMOE-3-PyP(5+) on diminished toxicity, improved efficacy and transport across the cell wall may originate from the favorable interplay of the size, length of pyridyl substituents, rotational flexibility (the ortho isomer, MnTE-2-PyP(5+), is more rigid, while MnTMOE-3-PyP(5+) is a more flexible meta isomer), bulkiness and presence of oxygen.
Figures





Similar articles
-
New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.Dalton Trans. 2004 Jun 7;(11):1696-702. doi: 10.1039/b400818a. Epub 2004 May 5. Dalton Trans. 2004. PMID: 15252564
-
Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.Inorg Chem. 2014 Nov 3;53(21):11467-83. doi: 10.1021/ic501329p. Epub 2014 Oct 21. Inorg Chem. 2014. PMID: 25333724 Free PMC article.
-
Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.Free Radic Biol Med. 2009 Jul 1;47(1):72-8. doi: 10.1016/j.freeradbiomed.2009.04.002. Epub 2009 Apr 8. Free Radic Biol Med. 2009. PMID: 19361553 Free PMC article.
-
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.Free Radic Biol Med. 2011 Sep 1;51(5):1035-53. doi: 10.1016/j.freeradbiomed.2011.04.046. Epub 2011 May 6. Free Radic Biol Med. 2011. PMID: 21616142 Free PMC article. Review.
-
A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.Anticancer Agents Med Chem. 2011 May 1;11(4):329-40. doi: 10.2174/187152011795677562. Anticancer Agents Med Chem. 2011. PMID: 21355843 Free PMC article. Review.
Cited by
-
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.Antioxid Redox Signal. 2014 May 20;20(15):2372-415. doi: 10.1089/ars.2012.5147. Epub 2013 Oct 1. Antioxid Redox Signal. 2014. PMID: 23875805 Free PMC article. Review.
-
Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues.J Inorg Biochem. 2017 Apr;169:50-60. doi: 10.1016/j.jinorgbio.2017.01.003. Epub 2017 Jan 5. J Inorg Biochem. 2017. PMID: 28131001 Free PMC article.
-
Mitochondrial metals as a potential therapeutic target in neurodegeneration.Br J Pharmacol. 2014 Apr;171(8):2159-73. doi: 10.1111/bph.12513. Br J Pharmacol. 2014. PMID: 24206195 Free PMC article. Review.
-
Metal complexes as potential modulators of inflammatory and autoimmune responses.Chem Sci. 2015 Feb 2;6(2):871-884. doi: 10.1039/c4sc03094j. Epub 2014 Nov 7. Chem Sci. 2015. PMID: 28660015 Free PMC article.
-
Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.Free Radic Res. 2011 Nov;45(11-12):1289-306. doi: 10.3109/10715762.2011.616199. Epub 2011 Sep 27. Free Radic Res. 2011. PMID: 21859376 Free PMC article.
References
-
- Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4 Oxford University Press; Oxford: 2007.
-
- Spasojevic I, Batinic-Haberle I. Superoxide dismutase mimics. In: Pantopoulos K, Schipper H, editors. Principles of Free Radical Biomedicine. Nova Science Publishers, Inc; Hauppauge, NY: 2011. in press.
-
- Batinic-Haberle I, Reboucas JS, Benov L, Spasojevic I. Chemistry, biology and medical effects of water-soluble metalloporphyrins. In: Kadish KM, Smith KM, Guilard R, editors. Handbook of Porphyrin Science. Vol. 11. World Scientific; 2010. pp. 291–393.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous